Continuouse Glucose Monitoring (CGM) is eliminating painful fingerpricks.

Fingerpricks gone and counting...

In November, we gave the people of Los Angeles and Seattle an idea of what it’s like to live with Type 1 diabetes. Check out their reactions when asked for a painful payment — a fingerprick.

CGM is changing the way people manage their diabetes, yet many are still unaware of the technology.

34%

of people with T1D know nothing or little about CGM

80%

of people with T1D still prick their fingers more than 3 times a day

96%

of CGM users would recommend CGM
 


According to a nationwide survey, people with Type 1 diabetes report that using CGM offers appealing benefits such as:

Alerts and Alarms

to proactively warn of dangerous highs & lows

Continuous Glucose Readings

sent automatically

No FingerPricks*

for calibration or treatment decisions

*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions

Learn More >

About diabetes management
from Beyond Type 1.

Explore Dexcom G6 >

The world's most advanced
diabetes management tool.

Instead of pricking their fingers,
Dexcom Warriors are...

Sailing the world from Baja California to French Polynesia.

Chase J.

Sailing the world from Baja California to French Polynesia.

Chase J.

Swimming around Key West, and paddling 100 miles, and writing a book called Islands and Insulin.

Erin S.

Touring the world, writing, producing and performing music he loves.

Eric P.

Zipping around the race track in the 24-hour series with his team.

Lance B.

Completing a six-month solo hike of the Appalachian Trail.

Rachel H.

Climbing some of the world’s tallest mountains and attending nursing school.

Chelsea G.

Skydiving in beautiful places around the globe.

Vanessa B.

Playing in the U.S. Open while chasing his professional tennis dreams.

JC A.

Sharing the importance of T1D education while mom runs a family business and daughter makes friends at her new school.

Keary and Zola C.